Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of “Moderate Buy” from Brokerages

Stevanato Group S.p.A. (NYSE:STVN) has earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company.

STVN has been the topic of several recent research reports. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. Wolfe Research assumed coverage on Stevanato Group in a research note on Friday, December 13th. They issued an “outperform” rating and a $28.00 target price on the stock. Finally, Bank of America raised their price target on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, December 13th.

Institutional Investors Weigh In On Stevanato Group

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Conestoga Capital Advisors LLC increased its position in Stevanato Group by 5.5% during the third quarter. Conestoga Capital Advisors LLC now owns 7,675,910 shares of the company’s stock worth $153,518,000 after purchasing an additional 400,087 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Stevanato Group by 67.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 2,784,912 shares of the company’s stock worth $55,698,000 after buying an additional 1,123,104 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Stevanato Group by 4.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after buying an additional 115,050 shares during the period. Bamco Inc. NY boosted its holdings in Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock valued at $33,704,000 after acquiring an additional 21,469 shares during the last quarter. Finally, Fred Alger Management LLC grew its position in Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after acquiring an additional 208,830 shares during the period.

Stevanato Group Stock Performance

STVN opened at €23.80 ($24.54) on Tuesday. The stock’s 50 day simple moving average is €21.18 and its 200 day simple moving average is €20.16. The stock has a market cap of $7.03 billion, a P/E ratio of 50.64, a P/E/G ratio of 10.49 and a beta of 0.56. Stevanato Group has a 1-year low of €16.56 ($17.07) and a 1-year high of €34.73 ($35.80). The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Tuesday, November 5th. The company reported €0.12 ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of €0.13 ($0.13) by (€0.01) (($0.01)). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The firm had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. During the same quarter in the prior year, the business earned $0.16 EPS. The company’s quarterly revenue was up 2.4% compared to the same quarter last year. As a group, equities analysts anticipate that Stevanato Group will post 0.5 EPS for the current fiscal year.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.